Mitochondrial DNA Deletions in Plasma as a Diagnostic Aid for Females Presenting With Symptoms of Endometriosis

Pearsanta, Inc

Status: Not yet enrolling

Conditions: Endometriosis

Treatments: Diagnostic Test: The Mitomic Endometriosis Test (MET) blood test for early detection of endometriosis

Study type: Observational

Funder types: Industry

Identifiers

NCT06907550

R2025-1001

Details and patient eligibility

About

This study will investigate the clinical performance and diagnostic accuracy of the Mitomic® Endometriosis Test (MET) compared to laparoscopic diagnosis in a prospective clinical study in females presenting with symptoms suggestive of endometriosis. This study will recruit patients with suspected endometriosis who have been referred for a diagnostic laparoscopy. Patients will complete a questionnaire about their endometriosis symptoms and a sample of blood will be taken prior to their laparoscopy and sent to the laboratory for the MET to be run.

This study aims to first enroll 104 subjects to support the clinical validation necessary for launch of the test as an LDT. Following this, we plan a study extension with an aim to enroll up to 900 more (for a total of 1000) subjects to enable more precise estimation of performance characteristics, characterization of test performance in subtypes of endometriosis, to better understand the relationship between test results and secondary endpoints such as symptoms and demographic variables, and to establish a bank of samples to support future test development.

Enrollment: 1,000 estimated patients

Sex: Female

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Be female, between menarche and menopause who present with symptoms of endometriosis at time of blood collection and are scheduled to undergo their first laparoscopic procedure for the diagnosis of endometriosis
2. Provide a blood sample prior to surgical procedure or administration of drugs related to the surgical procedure (i.e. anaesthetics, antibiotics)
3. Be fit to undergo all procedures listed in protocol
4. Be able to provide written informed consent

Exclusion criteria

1. Has had a prior surgical diagnosis of endometriosis at time of blood collection
2. Is unable to communicate in written and spoken English
3. Has any other condition, which in the opinion of the investigator, would make the subject not a suitable candidate for the study. This reason must be recorded on the CRF

Trial design

1,000 participants in 1 patient group

Females suspected of endometriosis scheduled for laparoscopic surgery

Description:

Females suspected of endometriosis scheduled for laparoscopic surgery

Treatment:

Diagnostic Test: The Mitomic Endometriosis Test (MET) blood test for early detection of endometriosis